China grants conditional approval to its homegrown COVID-19 vaccine

The approval comes a day after Sinopharm said its vaccine showed 79.34 per cent efficacy and a 99.52 per cent antibody-positive conversion rate in the interim results of the Phase III clinical trials.

from International-News-Economic Times https://ift.tt/2JvgYHg
via IFTTT

SHARE